Founded in 2011, the French Company is a French service provider or CRO (Contract Research Organisation), in the field of production, purification, formulation, and characterization of proteins.
The cell-free "technology" makes it possible to provide solutions to the main problems encountered with cellular expression: inclusion bodies, truncated proteins, unstable and cytotoxic proteins for example. From this technology, It is possible to express quickly and in quantity SIMPLE as DIFFICULT proteins. It can be membrane proteins in different formats: proteoliposomes, nanodiscs or solubilized.
This technology allows for example to provide membrane receptors which are then used to select biologic candidates by phage display.
Partnership can be considered via research or technical agreement or commercial agreement with technical assistance.
Via research or technical agreement:
- Any partner able to bring a technology or know-how to serve the scaling-up of a cell-free system;
Via commercial agreement with technical assistance:
- Industrial partner interested in cell-free expression technology: developing combined offers to increase cell-free system expertise, working as subcontractors or industrial partners working through cell systems and want to expand their offer with the cell-free expression system.
Dependent on the results, the French company and the partner will develop together a proof of concept.
There are many applications such as vaccine development, antibody development, drug discovery, in vitro diagnosis, structural biology and protein vectorization.
The French company is an expert for all these applications and allows you to focus on what matters for your projects development.